Bristol-Myers Squibb Co · Healthcare
Bristol-Myers Squibb Co (BMY) is a stock traded in US markets in the Healthcare sector. P/E 13.85, P/B 5.75, ROE 46.70% and dividend yield 3.72%. The P/E multiple helps compare this asset's valuation with other companies in the same sector. Explore the public market data tracked by FundamentalRadar. This page includes key fundamental indicators, recent distributions and financial statements available from the public sources tracked by FundamentalRadar.
The source returned no recent distributions for this asset.
Financial statements are not available for this asset yet.
The current price of BMY is $62.86.
The P/E ratio of BMY is 13.85, meaning investors pay 13.85 times earnings per share.
The P/B of BMY is 5.75, meaning the stock trades at 5.75 times its book value per share.
The ROE (Return on Equity) of BMY is 46.70%, meaning the company generates 46.70% of profit for every unit of shareholders' equity.
The dividend yield of BMY is 3.72%. This represents the annual dividend relative to the current share price.
The market capitalization of BMY is US$ 128.4 B.
The net profit margin of BMY is 18.87%, meaning the company keeps 18.87% of revenue as profit.
The debt-to-equity ratio of BMY is 2.02, meaning the company has 2.02 units of debt for each unit of equity.
BMY operates in the Healthcare sector.